After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Pliant Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Pliant Therapeutics Inc is $98.22M. A total of 1.57 million shares were traded on the day, compared to an average of 1.77M shares.
In the most recent transaction, Coulie Bernard sold 52,419 shares of PLRX for 11.20 per share on Jan 17 ’25. After the transaction, the President and CEO now owns 430,517 company shares. In a previous transaction on Jan 17 ’25, Cummings Keith Lamont sold 20,148 shares at 11.20 per share. PLRX shares that Chief Financial Officer owns now total 262,608.
Among the insiders who sold shares, Hull Hans disposed of 15,936 shares on Jan 17 ’25 at a per-share price of $11.20. This resulted in the Chief Business Officer holding 211,558 shares of PLRX after the transaction. In another insider transaction, Lefebvre Eric sold 18,478 shares at $11.20 per share on Jan 17 ’25. Company shares held by the Chief Medical Officer now total 194,574.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, PLRX has a high of $16.10 and a low of $1.10.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. PLRX’s latest balance sheet shows that the firm has $200.60M in Cash & Short Term Investments as of fiscal 2021. There were $7.19M in debt and $16.83M in liabilities at the time. Its Book Value Per Share was $4.19, while its Total Shareholder’s Equity was $199.06M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PLRX is Buy with a score of 3.33.